Literature DB >> 15857140

Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides.

Antonello Mai1, Silvio Massa, Riccardo Pezzi, Silvia Simeoni, Dante Rotili, Angela Nebbioso, Annamaria Scognamiglio, Lucia Altucci, Peter Loidl, Gerald Brosch.   

Abstract

Chemical manipulations performed on aroyl-pyrrolyl-hydroxyamides (APHAs) led to (aryloxopropenyl)pyrrolyl hydroxamates 2a-w, and their inhibition against maize HDACs and their class I or class II HDAC selectivity were determined. In particular, from these studies some benzene meta-substituted compounds emerged as highly class II (IIa)-selective HDAC inhibitors, the most selective being the 3-chloro- and 3-fluoro-substituted compounds 2c (SI = 71.4) and2f (SI = 176.4). The replacement of benzene with a 1-naphthyl ring afforded 2s, highly active against the class II homologue HD1-A (IC(50) = 10 nM) but less class II-selective than 2c,f. When tested against human HDAC1 and HDAC4, 2f showed no inhibitory activity against HDAC1 but was able to inhibit HDAC4. Moreover, in human U937 acute myeloid leukaemia cells 2f did not produce any effect on apoptosis, granulocytic differentiation, and the cell cycle, whereas 2s (that retain class I HDAC inhibitory activity) was 2-fold less potent than SAHA used as reference.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857140     DOI: 10.1021/jm049002a

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  60 in total

1.  HDAC5 catalytic activity suppresses cardiomyocyte oxidative stress and NRF2 target gene expression.

Authors:  Tianjing Hu; Friederike C Schreiter; Rushita A Bagchi; Philip D Tatman; Mark Hannink; Timothy A McKinsey
Journal:  J Biol Chem       Date:  2019-04-08       Impact factor: 5.157

2.  Nε-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heart.

Authors:  Claudia Colussi; Jessica Rosati; Stefania Straino; Francesco Spallotta; Roberta Berni; Donatella Stilli; Stefano Rossi; Ezio Musso; Emilio Macchi; Antonello Mai; Gianluca Sbardella; Sabrina Castellano; Cristina Chimenti; Andrea Frustaci; Angela Nebbioso; Lucia Altucci; Maurizio C Capogrossi; Carlo Gaetano
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

Review 3.  Histone deacetylase inhibitors and hemoglobin F induction in beta-thalassemia.

Authors:  Anna Rita Migliaccio; Dante Rotili; Angela Nebbioso; George Atweh; Antonello Mai
Journal:  Int J Biochem Cell Biol       Date:  2008-05-29       Impact factor: 5.085

4.  On the inhibition of histone deacetylase 8.

Authors:  Guillermina Estiu; Nathan West; Ralph Mazitschek; Edward Greenberg; James E Bradner; Olaf Wiest
Journal:  Bioorg Med Chem       Date:  2010-04-03       Impact factor: 3.641

Review 5.  Isoform-selective histone deacetylase inhibitors.

Authors:  Anton V Bieliauskas; Mary Kay H Pflum
Journal:  Chem Soc Rev       Date:  2008-05-08       Impact factor: 54.564

6.  Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice.

Authors:  Edwin F de Zoeten; Liqing Wang; Hong Sai; Wolfgang H Dillmann; Wayne W Hancock
Journal:  Gastroenterology       Date:  2009-10-29       Impact factor: 22.682

7.  Specific activity of class II histone deacetylases in human breast cancer cells.

Authors:  Vanessa Duong; Caroline Bret; Lucia Altucci; Antonello Mai; Céline Duraffourd; Julie Loubersac; Pierre-Olivier Harmand; Sandrine Bonnet; Sergio Valente; Thierry Maudelonde; Vincent Cavailles; Nathalie Boulle
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

Review 8.  Multiple roles of HDAC inhibition in neurodegenerative conditions.

Authors:  De-Maw Chuang; Yan Leng; Zoya Marinova; Hyeon-Ju Kim; Chi-Tso Chiu
Journal:  Trends Neurosci       Date:  2009-09-21       Impact factor: 13.837

9.  Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model.

Authors:  Luisa Quinti; Vanita Chopra; Dante Rotili; Sergio Valente; Allison Amore; Gianluigi Franci; Sarah Meade; Marta Valenza; Lucia Altucci; Michele M Maxwell; Elena Cattaneo; Steven Hersch; Antonello Mai; Aleksey Kazantsev
Journal:  PLoS Curr       Date:  2010-09-02

10.  Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes.

Authors:  Angela Nebbioso; Fabio Manzo; Marco Miceli; Mariarosaria Conte; Lucrezia Manente; Alfonso Baldi; Antonio De Luca; Dante Rotili; Sergio Valente; Antonello Mai; Alessandro Usiello; Hinrich Gronemeyer; Lucia Altucci
Journal:  EMBO Rep       Date:  2009-06-05       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.